Assessment the role of survivin and FOXO1 in patient with acne vulgaris in Babylon City
Keywords:
acne volgaris, survivin, FOXO1Abstract
Acne is a chronic inflammatory disease of the pilosebaceous unit resulting from androgen-induced increased sebum production,occurs most prominently at skin sites with a high density of sebaceous glands such as the face,chest, and back. Survivin is an evolutionarily conserved eukaryotic protein that is essential for cell division , can inhibit cell death, Normally it is only expressed in actively proliferating cells. Survivin has been found to be increased in keratinocyte proliferative and inflammatory states, which are deeply involved in the pathogenesis of the acne lesions.Foxo1 is considered to be a representative member of the FoxO family, and has key transcription regulatory activities FoxOs are homeostatic factors in healthy skin and in skin disorders,Foxo1 a master regulatory factor for gluconeogenesis and glycogenolysis, as well as a positive regulator of the expression of insulin, is part of signaling axes related to the control of epidermal morphogenesis and the pathogenesis of acne ,The study was a case –control design which conducted in dermatology Al-Musayyab General Hospital and Al Imam Sadiq Hospital,Murjan Teaching Hospital. with 45 patients with Acne volgaris and 45 healthy controls, the level of serum survivin and Foxo1 were measured using an enzyme-linked immunosorbent assay (ELISA).
Downloads
References
T.-X. Cong, D. Hao, X. Wen, X.-H. Li, G. He, and X. Jiang, “From pathogenesis of acne vulgaris to anti-acne agents,” Arch. Dermatol. Res., vol. 311, no. 5, pp. 337–349, 2019.
M. Wardhana, R. Vebryanti, G. A. Karmila, G. A. Praharsini, and R. S. Tallo, “Association between Psychological Stress and Insulin like Growth Factor-1 (IGF-1) with Acne Vulgaris,” 2021.
M. Filo-Rogulska, D. Wcisło-Dziadecka, and L. Ligia Brzezińska-Wcisło, “Neonatal and infantile acne-ethiopathogenesis, clinical presentation and treatment possibilities,” Postępy Nauk Med., vol. 31, no. 1A, pp. 45–48, 2018.
C. C. Zouboulis, E. Jourdan, and M. Picardo, “Acne and lipid pathways,” in Lipids and Skin Health, Springer, 2015, pp. 331–342.
M. Kawashima, T. Nagare, and M. Doi, “Clinical efficacy and safety of benzoyl peroxide for acne vulgaris: comparison between Japanese and Western patients,” J. Dermatol., vol. 44, no. 11, pp. 1212–1218, 2017.
A. Wong, B. Zhang, M. Jiang, E. Gong, Y. Zhang, and S. W. Lee, “Oxidative stress in acne vulgaris,” J Clin Dermatol Ther, vol. 3, p. 20, 2016.
D. Z. Eichenfield, J. Sprague, and L. F. Eichenfield, “Management of Acne Vulgaris: A Review,” JAMA, vol. 326, no. 20, pp. 2055–2067, 2021.
C. C. Zouboulis, “Acne as a chronic systemic disease,” Clin. Dermatol., vol. 32, no. 3, pp. 389–396, 2014.
S. P. Wheatley and D. C. Altieri, “Survivin at a glance,” J. Cell Sci., vol. 132, no. 7, p. jcs223826, 2019.
S. El-Tahlawi, N. Ezzat Mohammad, A. Mohamed El-Amir, and H. Sayed Mohamed, “Survivin and insulin-like growth factor-I: potential role in the pathogenesis of acne and post-acne scar,” Scars, Burn. Heal., vol. 5, p. 2059513118818031, 2019.
K. Romańska-Gocka, M. Woźniak, E. Kaczmarek-Skamira, and B. Zegarska, “The possible role of diet in the pathogenesis of adult female acne,” Adv. Dermatology Allergol. Dermatologii i Alergol., vol. 33, no. 6, pp. 416–420, 2016.
S. Guo, R. Mangal, C. Dandu, X. Geng, and Y. Ding, “Role of Forkhead Box Protein O1 (FoxO1) in Stroke: A Literature Review,” Aging Dis., vol. 13, no. 2, p. 521, 2022.
E. Chiefari et al., “Transcriptional regulation of glucose metabolism: the emerging role of the HMGA1 chromatin factor,” Front. Endocrinol. (Lausanne)., vol. 9, p. 357, 2018.
D. Tsitsipatis, L.-O. Klotz, and H. Steinbrenner, “Multifaceted functions of the forkhead box transcription factors FoxO1 and FoxO3 in skin,” Biochim. Biophys. Acta (BBA)-General Subj., vol. 1861, no. 5, pp. 1057–1064, 2017.
H. A. Assaf, W. M. Abdel-Maged, B. E. M. Elsadek, M. H. Hassan, M. A. Adly, and S. A. Ali, “Survivin as a novel biomarker in the pathogenesis of acne vulgaris and its correlation to insulin-like growth factor-I,” Dis. Markers, vol. 2016, 2016.
S. M. A. E. El Mokadem, S. A. E. Khashaba, N. M. Said, and A. M. S. Mostafa, “Serum survivin level as a novel biomarker in acne vulgaris patients,” Egypt. J. Hosp. Med., vol. 81, no. 3, pp. 1565–1570, 2020.
G. Aksoy Saraç, S. Kader, and T. Akdağ, “Elevated survivin levels in patients with acne vulgaris,” J. Cosmet. Dermatol..
N. F. Agamia, D. M. Abdallah, O. Sorour, B. Mourad, and D. N. Younan, “Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin‐like growth factor‐1 in patients with acne vulgaris and their relationship with diet,” Br. J. Dermatol., vol. 174, no. 6, pp. 1299–1307, 2016.
S. Y. M. Hanum, E. Nasrul, N. K. Jusuf, and E. Yerizel, “The Effect of Forkhead Box Class O1, Mammalian Target of Rapamycin Complex 1, Survivin, and Interleukin-17 on the Degree of Acne Vulgaris Based on Serum Levels,” Open Access Maced. J. Med. Sci., vol. 8, no. B, pp. 401–407, 2020.
M. Eyüboglu, I. Kalay, and D. Eyüboglu, “Evaluation of adolescents diagnosed with acne vulgaris for quality of life and psychosocial challenges,” Indian J. Dermatol., vol. 63, no. 2, p. 131, 2018.
V. Lajevardi, S. Z. Ghodsi, M. Daneshpazhooh, H. Kazemi, Z. Aryanian, and A. Goodarzi, “The relationship between body mass index and the severity of acne,” Iran. J. Dermatology, vol. 17, no. 1, pp. 13–17, 2014.
M. Mwanthi and A. L. Zaenglein, “Update in the management of acne in adolescence,” Curr. Opin. Pediatr., vol. 30, no. 4, pp. 492–498, 2018.
Almashhadani HA. Synthesis of a CoO–ZnO nanocomposite and its study as a corrosion protection coating for stainless steel in saline solution. Int. J. Corros. Scale Inhib. 2021;10(3):1294-306.
Parmin, P., Suarayasa, K., & Wandira, B. A. (2020). Relationship between quality of service with patient loyality at general polyclinic of kamonji public health center. International Journal of Health & Medical Sciences, 3(1), 86-91. https://doi.org/10.31295/ijhms.v3n1.157
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
